Samer Nasser

664 total citations
11 papers, 476 citations indexed

About

Samer Nasser is a scholar working on Epidemiology, Hepatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Samer Nasser has authored 11 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Hepatology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Samer Nasser's work include Liver Disease Diagnosis and Treatment (3 papers), Hepatitis C virus research (3 papers) and Hepatitis B Virus Studies (2 papers). Samer Nasser is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Hepatitis C virus research (3 papers) and Hepatitis B Virus Studies (2 papers). Samer Nasser collaborates with scholars based in United States, Germany and Switzerland. Samer Nasser's co-authors include Peter Buggisch, Thomas Berg, Ulrich Spengler, Tilman Gerlach, Gerd R. Pape, Tobias Goeser, Stefan Zeuzem, Christoph Sarrazin, Tobias Heintges and Hartwig Klinker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Samer Nasser

9 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samer Nasser United States 6 420 395 41 33 21 11 476
Donatella Ieluzzi Italy 8 174 0.4× 183 0.5× 20 0.5× 12 0.4× 21 1.0× 14 274
Camille Barrault France 7 115 0.3× 130 0.3× 22 0.5× 49 1.5× 32 1.5× 15 221
Felicidad Rodrı́guez Spain 8 219 0.5× 196 0.5× 8 0.2× 8 0.2× 88 4.2× 9 295
C Glaubke Germany 3 285 0.7× 264 0.7× 50 1.2× 4 0.1× 74 3.5× 3 313
Pandurangan Basumani United Kingdom 7 152 0.4× 199 0.5× 26 0.6× 7 0.2× 146 7.0× 13 319
F. Imai Japan 5 291 0.7× 196 0.5× 14 0.3× 4 0.1× 160 7.6× 5 337
Valentina Liakina Lithuania 8 83 0.2× 98 0.2× 10 0.2× 13 0.4× 32 1.5× 27 159
Yin Mei Lee Singapore 8 188 0.4× 213 0.5× 14 0.3× 7 0.2× 54 2.6× 14 260
Klintmalm Gb United States 12 186 0.4× 89 0.2× 6 0.1× 18 0.5× 240 11.4× 25 370
Diego Casas Deza Spain 9 36 0.1× 72 0.2× 12 0.3× 34 1.0× 40 1.9× 36 201

Countries citing papers authored by Samer Nasser

Since Specialization
Citations

This map shows the geographic impact of Samer Nasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer Nasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer Nasser more than expected).

Fields of papers citing papers by Samer Nasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer Nasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer Nasser. The network helps show where Samer Nasser may publish in the future.

Co-authorship network of co-authors of Samer Nasser

This figure shows the co-authorship network connecting the top 25 collaborators of Samer Nasser. A scholar is included among the top collaborators of Samer Nasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer Nasser. Samer Nasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cruz, D., Guoqiang Wan, A.-M. van Dam, et al.. (2024). Heterozygous Mutations in Three Novel Candidate Genes, IFT122, WDR19, and WDR35, Cause Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 35(10S).
2.
Mutter, Walter P., et al.. (2019). Nutritional and Medical Management of Kidney Stones. 7 indexed citations
3.
Nasser, Samer, et al.. (2019). Oxymorphone Induced Thrombotic Microangiopathy Mimicking Atypical Haemolytic Uremic Syndrome.. PubMed. 29(2). 360–362.
4.
Nasser, Samer, et al.. (2016). Diffuse leukoencephalopathy in a 29-year-old male with hypertensive emergency. BJR|case reports. 2(4). 20150199–20150199. 1 indexed citations
5.
Nasser, Samer, et al.. (2013). Multiple Pulmonary Nodules: A Complex Case of Wegener’s Granulomatosis. SHILAP Revista de lepidopterología. 3(1). e14–e14. 3 indexed citations
6.
Nasser, Samer, et al.. (2012). A rare case of spinal dural arteriovenous fistula. SHILAP Revista de lepidopterología. 4(3). 19–19. 5 indexed citations
7.
Darko, William, et al.. (2010). Rhabdomyolysis associated with phentermine. American Journal of Health-System Pharmacy. 67(22). 1929–1932. 11 indexed citations
8.
Chabrot, P., L. Cassagnes, Samer Nasser, et al.. (2010). Revascularization of traumatic renal artery dissection by endoluminal stenting: Three cases. Acta Radiologica. 51(1). 21–26. 11 indexed citations
9.
Kronenberger, Bernd, Thomas Berg, Eva Herrmann, et al.. (2007). Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-α and ribavirin: results from a randomized, placebo-controlled, double-blind trial. European Journal of Gastroenterology & Hepatology. 19(8). 639–646. 15 indexed citations
10.
Berg, Thomas, Michael Wagner, Samer Nasser, et al.. (2006). Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin. Gastroenterology. 130(4). 1086–1097. 368 indexed citations
11.
Berg, Thomas, Bernd Kronenberger, Holger Hinrichsen, et al.. (2003). Triple Therapy With Amantadine in Treatment–Naive Patients With Chronic Hepatitis C: A Placebo–Controlled Trial. Hepatology. 37(6). 1359–1367. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026